Revolving Door in Biotech?

WASHINGTON—Employees in the biotechnology industry are enjoying more salary increases, cash incentive programs and educational assistance, yet the annual turnover rate for some positions is as high as 23 percent, according to a recent survey conducted by Radford Associates for the Industrial Biotechnology Association. The Biotechnology Compensation and Benefits Survey collected information from 126 biotechnology companies based primarily in the United States and Canada. Salary increases we

January 26, 1987

WASHINGTON—Employees in the biotechnology industry are enjoying more salary increases, cash incentive programs and educational assistance, yet the annual turnover rate for some positions is as high as 23 percent, according to a recent survey conducted by Radford Associates for the Industrial Biotechnology Association.

The Biotechnology Compensation and Benefits Survey collected information from 126 biotechnology companies based primarily in the United States and Canada. Salary increases were found to average 6.8 percent for all job categories.

The highest turnover was found in the lower-paying entry level jobs. "Companies are finding they'll have to become competitive with their base salaries," said John Radford of Radford Associates. When the biotechnology industry was emerging, he said, many companies had a lock on their employees. "But now the honeymoon's over. Biotech companies will have to compete to keep their employees just like everyone else."

Popular Now

  1. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. Consilience, Episode 3: Cancer, Obscured
  4. A History of Screening for Natural Products to Fight Cancer
AAAS